Oral Minoxidil and Diphenhydramine Interaction: What You Need to Know

Do oral minoxidil and diphenhydramine interact?

No interaction between the two appears in the oral minoxidil tablet label. Its drug interactions section points to a single entry, guanethidine [1]. Here is what each medicine is known to do on its own.

One correction to a common assumption first: the minoxidil label states that minoxidil does not interfere with vasomotor reflexes and therefore does not produce orthostatic hypotension [1]. The blood-pressure effect at hair-loss doses is also small on average. In a 2025 meta-analysis of studies using 5 mg/day or less, systolic pressure changed by -0.13 mm Hg (95% CI -2.67 to 2.41) and diastolic by -1.25 mm Hg (-3.21 to 0.71), neither statistically significant [4]. What the evidence describes is drowsiness from the antihistamine and, in a minority, lightheadedness or a faster heart rate from minoxidil [2][3][4].

What the minoxidil label says about interactions

With guanethidine, the label says minoxidil can cause profound orthostatic effects, that guanethidine should be discontinued well before minoxidil is started where possible, and that where this is not possible minoxidil is started in hospital [1].

The rest of the label is written for antihypertensive doses: start at 5 mg once daily, increase to 10, 20 then 40 mg, with a maximum of 100 mg/day [1]. The label says use of minoxidil tablets to promote hair growth is not an approved indication, so low-dose use for hair loss is off-label [1]. Studies of low-dose use include doses up to 5 mg daily, which is also the labeled starting dose for hypertension [1][4]. The tablet's boxed warning describes pericardial effusion and worsening angina [1]. Low-dose studies also report fluid retention and tachycardia [3].

Where the two drugs overlap

Drowsiness. The Benadryl Allergy Drug Facts say marked drowsiness may occur, that alcohol, sedatives and tranquilizers may increase drowsiness, and to be careful when driving or operating machinery [2]. In a driving-simulator trial of 40 licensed drivers aged 25 to 44 with seasonal allergic rhinitis, a single 50 mg dose of diphenhydramine produced the poorest driving performance of four treatments, with lane keeping impaired after both diphenhydramine and alcohol at about 0.1% blood alcohol, and self-reported drowsiness did not predict impairment [6]. The oral minoxidil label says the drug did not enter the central nervous system in significant amounts in experimental animals and does not affect central nervous system function in man [1].

Lightheadedness. In a retrospective study of 1,404 patients on low-dose oral minoxidil, lightheadedness was reported in 1.7%, fluid retention in 1.3% and tachycardia in 0.9%, and 29 patients (1.2%) stopped treatment because of systemic effects [3]. Beers 2023 separately advises avoiding any combination of three or more CNS-active drugs in older adults because of falls and fracture risk [7].

Heart rate. Minoxidil increases heart rate, and the label says a beta blocker or other sympathetic suppressant is usually needed with it to prevent tachycardia and increased myocardial workload [1]. The 2025 meta-analysis found a mean heart-rate increase of 2.67 beats per minute (95% CI 0.34 to 5.01) at doses of 5 mg/day or less [4].

Does the low dose change the picture?

The systolic and diastolic changes across uncontrolled studies of 5 mg/day or less were not statistically significant [4]. But 119 patients in that analysis (5.0%) reported hypotensive symptoms, even though no hypotensive episodes were recorded [4]. A meta-regression of six studies in androgenetic alopecia found that each additional 1 mg/day of low-dose oral minoxidil was associated at six months with a 4.8% mean difference in cardiovascular adverse-event risk and a 17.9% mean difference in hypertrichosis risk [8]. That analysis was observational, so it shows association rather than cause [8].

Diphenhydramine in adults 65 and older

The 2023 AGS Beers Criteria advise avoiding first-generation antihistamines, including oral diphenhydramine, in adults 65 and older, a strong recommendation based on moderate-quality evidence, citing their strong anticholinergic effects and the risk of confusion, dry mouth and constipation [5]. The criteria also advise avoiding anticholinergics in people with dementia or cognitive impairment, in delirium or at high risk of it, and in those with a history of falls or fractures [5]. They note that diphenhydramine may be appropriate for acute treatment of a severe allergic reaction [5]. This guidance concerns diphenhydramine and is independent of minoxidil.

Is there a metabolic interaction?

Not one that the minoxidil label describes. About 90% of an oral minoxidil dose is metabolized, mainly by glucuronide conjugation, and the label does not name a CYP enzyme for it [1]. Diphenhydramine does inhibit CYP2D6: in 16 healthy men, steady-state diphenhydramine halved metoprolol's oral and nonrenal clearance and cut its alpha-hydroxylation clearance 2.5-fold in CYP2D6 extensive metabolizers, with stronger and longer-lasting heart-rate and blood-pressure effects from metoprolol [9]. Metoprolol was the drug tested in that study, not minoxidil [9].

Other label points on diphenhydramine

• The Benadryl label says not to use it with any other product containing diphenhydramine, even one used on skin [2].
• The FDA warned in 2020 that taking more than the recommended dose of OTC diphenhydramine can cause serious heart problems, seizures, coma or death [10]. The label dose for adults and children 12 and over is 25 to 50 mg every 4 to 6 hours, no more than 6 times in 24 hours [2].